go to main content
Partners News
Results (50)

Filter results

Partners

Radboudumc and Terumo Europe N.V. sign collaboration agreement

3 June 2022

Together, the two partners will improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads.

Simmunext: where immunotherapy and chemistry meet

2 June 2022

The story behind Radboud university medical center’s, Radboud University’s and Oncode’s newest spinoff, Simmunext Biotherapeutics B.V.

More accurate surgery with the Anatomy Projector

30 May 2022

The Anatomy Projector, developed at the Radboudumc, allows surgeons to operate much more accurately with projected augmented reality.

Investment in ARNE helps neonatologists make better decisions when treating newborn babies

28 April 2022

ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child.

Radboudumc receives grant from Nationaal Groeifonds Investments in Biotech Booster, Oncode-PACT and PharmaNL

19 April 2022

The Nationaal Groeifonds awards large grants to three consortia of which the Radboudumc is a member. Oncode-PACT, PharmaNL and Biotech Booster will receive amounts ranging from 80 to 325 million euros.